Morgan, C. L., Jenkins-Jones, S. ., Evans, M. ., Barnett, A. H., Poole, C. D., & Currie, C. J. (2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x
A. Barnett
First name
A.
Middle name
H.
Last name
Barnett
Morgan, C. L., Poole, C. D., Evans, M. ., Barnett, A. H., Jenkins-Jones, S. ., & Currie, C. J. (2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034
Holden, S. H., Barnett, A. H., Peters, J. R., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123
Watson, L. ., Das, R. ., Farquhar, R. ., Langerman, H. ., & Barnett, A. H. (2016). Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database. Curr Med Res Opin. http://doi.org/10.1185/03007995.2016.1157462